[Severe refractory eosinophilic asthma].
.
Dagmar
D
Jäger-Becker
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000188:drug therapy*; D006801:Humans; D015848:Interleukin-5 / Q000037:antagonists & inhibitors*
D018927:Anti-Asthmatic Agents; D061067:Antibodies, Monoclonal, Humanized; D015848:Interleukin-5; C434107:mepolizumab